A treatment to prevent the body's immune system from killing brain cells can reduce the brain damage caused by head injuries, a study co-authored by an Indian origin researcher has found.
An immune-based treatment reduced the size of brain lesions, the experiments on mice showed.
The treatment called CAP (competitive antagonist peptide) was successful because it stops the immune system from attacking the brain, the researchers said.
If the findings apply to humans, this would help prevent brain damage after accidents, they added.
The researchers were testing the theory that blows to the head cause brain damage, in part, because of the breakdown of the blood-brain barrier, allowing the immune cells in the blood to come into contact with brain cells and destroy them.
So they hypothesised that mice, missing a vital immune component, would have less brain damage from trauma, and that a treatment which blocks a component of the immune system would prevent damage.
The component they were working on was CD74, which plays a crucial part in the immune system's response to disease causing agents.
"The data support the hypothesis that neuro-degeneration following TBI (traumatic brain injury) is dependent upon antigen processing and requires CD74," said co-author Sanjib Mukherjee from Central Texas Veterans Health Care System, Texas in the US.
They tested this theory by a range of tests involving a total of 32 mice.
The mice that received the CAP treatment had smaller brain lesions, suggesting that it did reduce the damage caused by brain trauma.
The study appeared in the open access journal Acta Neuropathologica Communications.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
